Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Get up to date on optimal use of BTK inhibitors in the care of your patients with CLL with an interactive on-demand Webcast and downloadable slides from a live Webinar along with expert commentaries and our BTK Inhibitor AE Management Tool.

Share

Program Content

Activities

BTK Inhibitors in CLL
My Perspective on 3 Questions I Am Asked on BTK Inhibitors for CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2020

Expires: November 15, 2021

BTKi in CLL: FAQ
Expert Answers to Frequently Asked Questions on BTK Inhibitors for Treatment of CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 15, 2021

Expires: January 14, 2022

Activities

Overview: BTK Inhibitors in CLL
Overview of the BCR Pathway and Use of BTK Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Selecting First-line Therapy in CLL
Addressing the Medical Need in CLL: Selecting First-line Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

BTK Inhibition in R/R CLL
BTK Inhibitors for Relapsed/Refractory Chronic Lymphocytic Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

<i>EP</i>: BTK Inhibitors in CLL
ExpressPoints: Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.